These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28468961)

  • 1. Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.
    Wysocki J; Goodling A; Burgaya M; Whitlock K; Ruzinski J; Batlle D; Afkarian M
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F487-F494. PubMed ID: 28468961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Renin in Patients and Mice With Diabetic Kidney Disease.
    Tang J; Wysocki J; Ye M; Vallés PG; Rein J; Shirazi M; Bader M; Gomez RA; Sequeira-Lopez MS; Afkarian M; Batlle D
    Hypertension; 2019 Jul; 74(1):83-94. PubMed ID: 31079532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on role of direct renin inhibitor in diabetic kidney disease.
    Dhakarwal P; Agrawal V; Kumar A; Goli KM; Agrawal V
    Ren Fail; 2014 Jul; 36(6):963-9. PubMed ID: 24678880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
    St Peter WL; Odum LE; Whaley-Connell AT
    Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitriol regulates angiotensin-converting enzyme and angiotensin converting-enzyme 2 in diabetic kidney disease.
    Lin M; Gao P; Zhao T; He L; Li M; Li Y; Shui H; Wu X
    Mol Biol Rep; 2016 May; 43(5):397-406. PubMed ID: 26968558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
    Rodriguez F; Lee DJ; Gad SS; Santos MP; Beetel RJ; Vasey J; Bailey RA; Patel A; Blais J; Weir MR; Dash R
    Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.
    Soler MJ; Wysocki J; Ye M; Lloveras J; Kanwar Y; Batlle D
    Kidney Int; 2007 Sep; 72(5):614-23. PubMed ID: 17579661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Treatment of Prostaglandin E1 and Angiotensin-Converting Enzyme Inhibitor in Diabetic Kidney Disease Rats: Possible Role of Antiapoptosis in Renal Tubular Epithelial Cells.
    Mou Y; Zhang Y; Guo C; Zhao J; Zhang Z; Zhou X; Dong J; Liao L
    DNA Cell Biol; 2018 Feb; 37(2):133-141. PubMed ID: 29185789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.
    Tikellis C; Johnston CI; Forbes JM; Burns WC; Burrell LM; Risvanis J; Cooper ME
    Hypertension; 2003 Mar; 41(3):392-7. PubMed ID: 12623933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?
    Miyazaki H; Babazono A; Nishi T; Maeda T; Imatoh T; Ichiba M; Une H
    BMC Pharmacol Toxicol; 2015 Sep; 16():22. PubMed ID: 26362195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary peptide analysis to predict the response to blood pressure medication.
    Jaimes Campos MA; Mavrogeorgis E; Latosinska A; Eder S; Buchwinkler L; Mischak H; Siwy J; Rossing P; Mayer G; Jankowski J
    Nephrol Dial Transplant; 2024 Apr; 39(5):873-883. PubMed ID: 37930730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes.
    Tikellis C; Brown R; Head GA; Cooper ME; Thomas MC
    Am J Physiol Renal Physiol; 2014 Apr; 306(7):F773-80. PubMed ID: 24477684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2.
    Chang SY; Chen YW; Chenier I; Tran Sle M; Zhang SL
    Exp Diabetes Res; 2011; 2011():521076. PubMed ID: 22110472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anemia in patients with type II diabetes and mild to moderate chronic kidney disease and the impact of anti-RAS medications.
    Dousdampanis P; Trigka K; Fourtounas C
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):552-7. PubMed ID: 24821151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes.
    Diao TY; Pan H; Gu SS; Chen X; Zhang FY; Wong MS; Zhang Y
    J Bone Miner Metab; 2014 May; 32(3):261-70. PubMed ID: 23934056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of angiotensin converting enzyme 2 in the rodent retina.
    Tikellis C; Johnston CI; Forbes JM; Burns WC; Thomas MC; Lew RA; Yarski M; Smith AI; Cooper ME
    Curr Eye Res; 2004 Dec; 29(6):419-27. PubMed ID: 15764086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes.
    Schievink B; Kröpelin T; Mulder S; Parving HH; Remuzzi G; Dwyer J; Vemer P; de Zeeuw D; Lambers Heerspink HJ
    Diabetes Obes Metab; 2016 Jan; 18(1):64-71. PubMed ID: 26434564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!
    Malek V; Suryavanshi SV; Sharma N; Kulkarni YA; Mulay SR; Gaikwad AB
    Rev Physiol Biochem Pharmacol; 2021; 179():31-71. PubMed ID: 32979084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.